Newsfeeds - Spark Newswire

2 minute read

Earnings

Charles River’s Return On Capital Employed Overview

Today, 3:58 PM

Pulled from Benzinga Pro data, Charles River (NYSE:CRL) showed a loss in earnings since Q4, totaling $95.23 million. Sales, on the other hand, increased by 0.98% to $913.93 million during Q1.

CRL

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 3:58 PM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC

33 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 3:58 PM

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

2 minute read

Analyst Ratings

Wells Fargo Maintains Overweight Rating for Charles River: Here’s What You Need To Know

By Benzinga Insights

Today, 3:58 PM

Wells Fargo has decided to maintain its Overweight rating of Charles River (NYSE:CRL) and lower its price target from $390.00 to $325.00. Shares of Charles River are trading down 7.96% over the last 24 hours, at $251.29 per share.

CRL

2 minute read

Analyst Ratings

What 6 Analyst Ratings Have To Say About Charles River

By Benzinga Insights

Today, 3:58 PM

Analysts have provided the following ratings for Charles River (NYSE:CRL) within the last quarter:

CRL

1 minute read

Charles River Buys Contract Vivarium Research Services Firm In $295M Deal

By Vandana Singh

Today, 3:58 PM

Charles River Laboratories International Inc (NYSE: CRL) has acquired Explora BioLabs Holdings Inc, a provider of contract vivarium research services,

CRL

2 minute read

Earnings

Charles River Earnings Perspective: Return On Invested Capital

By Benzinga Insights

Today, 3:58 PM

According to Benzinga Pro, during Q4, Charles River (NYSE:CRL) earned $139.83 million, a 32.97% increase from the preceding quarter. Charles River also posted a total of $905.05 million in sales, a 1.02% increase since Q3.

CRL

1 minute read

Keybanc Maintains Overweight on Charles River, Lowers Price Target to $390

By Benzinga Newsdesk

Today, 3:58 PM

Keybanc analyst Donald Hooker maintains Charles River (NYSE:CRL) with a Overweight and lowers the price target from $450 to $390.

CRL

1 minute read

Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

By Vandana Singh

Today, 3:58 PM

Charles River Laboratories International Inc's (NYSE: CRL)

CRL

1 minute read

Charles River Q4 EPS $2.49 Beats $2.43 Estimate, Sales $905.05M Beat $888.27M Estimate

By Benzinga Newsdesk

Today, 3:58 PM

Charles River (NYSE:CRL) reported quarterly earnings of $2.49 per share which beat the analyst consensus estimate of $2.43 by 2.47 percent. This is a 4.18 percent increase over earnings of $2.39 per share from the same

CRL